Altamira TherapeuticsCYTO 
$0.10-19.93%24h
-19.93%24h
Global rank
Market cap$136.00K
Change 7d-76.20%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Altamira Therapeutics (CYTO)
As of January 2025, Altamira Therapeutics has a market cap of $136.00K. This makes Altamira Therapeutics the world's th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Altamira Therapeutics from 2014 to 2024
-
Value:-
Market cap history of Altamira Therapeutics from 2014 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $2.67M | -45.98% |
| 2023 | $4.93M | -96.41% |
| 2022 | $137.53M | -86.64% |
| 2021 | $1.03B | -30.73% |
| 2020 | $1.49B | 61.73% |
| 2019 | $918.75M | -82.24% |
| 2018 | $5.17B | -92.28% |
| 2017 | $67.03B | -44.77% |
| 2016 | $121.37B | -78.12% |
| 2015 | $554.65B | 25.38% |
| 2014 | $442.36B | - |
CYTO Market Cap Today is $136.00K -19.93% - 6 Jan 2025
View largest stocks by market cap 
